CN100364994C - 培美曲塞二钠的一种新晶型及其制备方法 - Google Patents
培美曲塞二钠的一种新晶型及其制备方法 Download PDFInfo
- Publication number
- CN100364994C CN100364994C CNB2004100972832A CN200410097283A CN100364994C CN 100364994 C CN100364994 C CN 100364994C CN B2004100972832 A CNB2004100972832 A CN B2004100972832A CN 200410097283 A CN200410097283 A CN 200410097283A CN 100364994 C CN100364994 C CN 100364994C
- Authority
- CN
- China
- Prior art keywords
- hydrate
- cancer
- disodium
- pemetrexed disodium
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
d-间距() | I/I<sub>0</sub> | d-间距() | I/I<sub>0</sub> | d-间距() | I/I<sub>0</sub> |
33.0019.1811.579.518.627.876.305.995.74 | 112122392411252660 | 5.154.964.824.654.283.903.743.453.31 | 2862473818100803929 | 3.243.143.112.972.582.602.29 | 18334923111617 |
培美曲塞二钠水合物 | d-间距() | I/I<sub>0</sub> |
2.5水合物七水合物三水合物 | 18.66±0.047.78±0.043.90或3.74±0.04 | 100100100 |
培美曲塞二钠水合物 | 含 水 量(%) | ||||
0小时 | 0.5小时 | 1.0小时 | 1.5小时 | 2.0小时 | |
2.5水合物七水合物三水合物 | 8.821.210.1 | 9.521.010.0 | 10.120.410.3 | 10.720.010.5 | 11.219.310.9 |
培美曲塞二钠水合物 | 含 水 量(%) | ||||
0月 | 1月 | 2月 | 3月 | 6月 | |
2.5水合物七水合物三水合物 | 8.921.310.4 | 8.919.010.2 | 8.717.110.6 | 9.015.810.3 | 8.712.910.0 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100972832A CN100364994C (zh) | 2004-11-25 | 2004-11-25 | 培美曲塞二钠的一种新晶型及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100972832A CN100364994C (zh) | 2004-11-25 | 2004-11-25 | 培美曲塞二钠的一种新晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1778802A CN1778802A (zh) | 2006-05-31 |
CN100364994C true CN100364994C (zh) | 2008-01-30 |
Family
ID=36769266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100972832A Active CN100364994C (zh) | 2004-11-25 | 2004-11-25 | 培美曲塞二钠的一种新晶型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100364994C (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101092417B (zh) * | 2006-06-19 | 2011-04-27 | 上海金色医药科技发展有限公司 | 一种叶酸类似物及用于医疗的叶酸类似物的盐 |
CN101417998B (zh) | 2007-10-24 | 2012-10-24 | 重庆医药工业研究院有限责任公司 | 一种培美曲塞盐的纯化方法 |
EP2334685A4 (en) * | 2008-09-08 | 2011-10-26 | Reddys Lab Ltd Dr | AMORPHOUS PEMETREXED DISODIUM |
CN102050825B (zh) * | 2009-11-05 | 2014-12-17 | 上海创诺制药有限公司 | 制备培美曲塞二钠2.5水结晶的方法 |
US9174991B2 (en) | 2009-11-24 | 2015-11-03 | Azad Pharmaceutical Ingredients Ag | Crystalline form of pemetrexed disodium |
CN102086204B (zh) * | 2010-12-27 | 2012-08-29 | 江苏奥赛康药业股份有限公司 | 一种高纯度培美曲塞二钠的工业化生产方法 |
CN102106833B (zh) * | 2011-02-12 | 2012-05-02 | 海南锦瑞制药股份有限公司 | 一种培美曲塞二钠冻干粉针剂及其制备方法 |
AU2011363636B2 (en) * | 2011-03-25 | 2016-03-17 | Scinopharm Taiwan Ltd | Process for the production of a pemetrexed salt |
CN102977107B (zh) * | 2012-12-25 | 2015-04-22 | 山西普德药业股份有限公司 | 一种培美曲塞二钠化合物及其组合物 |
JP2016527227A (ja) | 2013-07-16 | 2016-09-08 | ドクター レディズ ラボラトリーズ リミテッド | ペメトレキセドトロメタミン塩の新規な結晶形 |
CN104119345B (zh) * | 2014-06-18 | 2016-04-27 | 威海昊同医药科技有限公司 | 一种注射级培美曲塞二钠的纯化方法 |
CN105985326B (zh) * | 2015-02-16 | 2020-04-14 | 上海宣创生物科技有限公司 | 嘧啶衍生物晶型ⅲ及其制备方法和用途 |
CN115252564A (zh) * | 2022-08-30 | 2022-11-01 | 海南锦瑞制药有限公司 | 一种注射用培美曲塞二钠的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1406238A (zh) * | 2000-02-25 | 2003-03-26 | 伊来利利公司 | N-[4-[2-(2-氨基-4,7-二氢-4-氧代-3H-吡咯并[2,3-d]嘧啶-5-基)乙基]苯甲酰基]-L-谷氨酸的一种新晶形及其制备方法 |
-
2004
- 2004-11-25 CN CNB2004100972832A patent/CN100364994C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1406238A (zh) * | 2000-02-25 | 2003-03-26 | 伊来利利公司 | N-[4-[2-(2-氨基-4,7-二氢-4-氧代-3H-吡咯并[2,3-d]嘧啶-5-基)乙基]苯甲酰基]-L-谷氨酸的一种新晶形及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1778802A (zh) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100364994C (zh) | 培美曲塞二钠的一种新晶型及其制备方法 | |
CN102086195B (zh) | 达沙替尼多晶型物及其制备方法和药用组合物 | |
US20180291005A1 (en) | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | |
CN105153122A (zh) | [(吲哚-3-基)嘧啶-2-基]氨基苯基丙-2-烯酰胺衍生物及盐、制备方法、应用 | |
EP2861589A2 (en) | Multicomponent crystals comprising dasatinib and selected cocrystal formers | |
CN112047892B (zh) | 一种吉非替尼与3-羟基苯甲酸共晶体 | |
CN105175422B (zh) | 一种磷酸西格列汀晶体及其制备方法和用途 | |
CN110283131A (zh) | 一种吉非替尼与香草酸共晶甲醇溶剂合物及其制备方法 | |
CN112047893B (zh) | 吉非替尼与水杨酸共晶体 | |
CN106349192B (zh) | 奥利司他与氨基酸的共晶体及包含该共晶体的药物组合物 | |
CN103965116A (zh) | 半5-氟胞嘧啶盐、其制备方法及应用 | |
CA2879792A1 (en) | Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof | |
CN105198947B (zh) | 一种Trifluridine化合物及其药物组合物 | |
EP4219476A1 (en) | Salt of arylaminoquinazoline-containing compound, and preparation method therefor and use thereof | |
CN106478636B (zh) | 替格瑞洛晶型及制备方法 | |
CN101787049B (zh) | 辅羧酶四水合物的新晶型及其制备方法 | |
CN112457365B (zh) | 一类靶向蛋白质水解通路的功能分子及其制备和应用 | |
CN108264465B (zh) | 盐酸达泊西汀一水合物及其制备方法和用途 | |
CN109516991B (zh) | 一种枸橼酸托法替尼晶型化合物及其制备方法 | |
CN102924449B (zh) | 盐酸莫西沙星h晶型及其制备方法和药物组合物 | |
CN105566294A (zh) | 一种右旋艾普拉唑钠化合物及其药物组合物 | |
CN105753938A (zh) | 一种匹多莫德晶型及其制备方法和用途 | |
CN106279201A (zh) | 一种稠合嘧啶类衍生物马来酸盐、晶体、制备方法及应用 | |
CN101709066A (zh) | 一种四水合辅羧酶的新晶型及其制备方法 | |
CN103724359B (zh) | 一种无定形头孢替坦酸及由其制备头孢替坦二钠的方法和含有该头孢替坦二钠的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090515 Address after: 565 zip code of Tu Shan Road, Nanan District, Chongqing: 400061 Co-patentee after: Shanghai Chemo Wanbang Biopharma Co., Ltd. Patentee after: Chongqing pharmaceutical industry research institute limited liability company Address before: 565 zip code of Tu Shan Road, Nanan District, Chongqing: 400061 Co-patentee before: Shanghai Clonbiotech Co., Ltd. Patentee before: Chongqing pharmaceutical industry research institute limited liability company |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190201 Address after: 401221 No. 2 Yanjiahua South Third Branch Road, Changshou District, Chongqing Co-patentee after: Chongqing Pharmaceutical Research Institute Co., Ltd. Patentee after: Chongqing Medical Institute Pharmaceutical Co., Ltd. Co-patentee after: Shanghai Chemo Wanbang Biopharma Co., Ltd. Address before: 400061 Tu Shan Road, South Bank district, Chongqing, No. 565 Co-patentee before: Shanghai Chemo Wanbang Biopharma Co., Ltd. Patentee before: Chongqing Pharmaceutical Research Institute Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200416 Address after: 401221, No. 3, No. 1 South Road, Changshou chemical industry park, Chongqing Co-patentee after: CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd. Patentee after: CHONGQING CARELIFE PHARMACEUTICAL Co.,Ltd. Co-patentee after: SHANGHAI CHEMO WANBANG BIOPHARMA Co.,Ltd. Address before: 401221 No. 2 Yanjiahua South Third Branch Road, Changshou District, Chongqing Co-patentee before: CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE Co.,Ltd. Patentee before: Chongqing Medical Institute Pharmaceutical Co., Ltd. Co-patentee before: SHANGHAI CHEMO WANBANG BIOPHARMA Co.,Ltd. |